Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
2.

Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.

Lloyd S, Baraghoshi D, Tao R, Garrido-Laguna I, Gilcrease GW 3rd, Whisenant J, Weis JR, Scaife C, Pickron TB, Huang LC, Monroe MM, Abdelaziz S, Fraser AM, Smith KR, Deshmukh V, Newman M, Rowe KG, Snyder J, Samadder NJ, Hashibe M.

Am J Clin Oncol. 2019 Mar 5. doi: 10.1097/COC.0000000000000529. [Epub ahead of print]

PMID:
30844850
3.

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.

Kinsey CG, Camolotto SA, Boespflug AM, Gullien KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M.

Nat Med. 2019 Mar 4. doi: 10.1038/s41591-019-0367-9. [Epub ahead of print]

PMID:
30833748
4.

Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.

Swords DS, Skarda DE, Sause WT, Gawlick U, Cannon GM, Lewis MA, Scaife CL, Gygi JA, Tae Kim H.

J Gastrointest Surg. 2019 Apr;23(4):659-669. doi: 10.1007/s11605-019-04107-1. Epub 2019 Jan 31.

PMID:
30706375
5.

Advances in surgery for pancreatic cancer.

Acher AW, Bleicher J, Cannon A, Scaife C.

J Gastrointest Oncol. 2018 Dec;9(6):1037-1043. doi: 10.21037/jgo.2018.05.05. Review.

6.

Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.

Swords DS, Mulvihill SJ, Brooke BS, Skarda DE, Firpo MA, Scaife CL.

Surgery. 2019 Apr;165(4):751-759. doi: 10.1016/j.surg.2018.10.035. Epub 2018 Dec 11.

PMID:
30551868
7.

Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.

Swords DS, Brooke BS, Skarda DE, Stoddard GJ, Tae Kim H, Sause WT, Scaife CL.

J Gastrointest Surg. 2018 Nov 12. doi: 10.1007/s11605-018-4039-8. [Epub ahead of print]

PMID:
30421120
8.

Safety of implementing a sleep protocol in hospitalized patients.

Patterson MM, Scaife CL, Doig AK.

Am J Surg. 2018 Oct 14. pii: S0002-9610(18)30428-8. doi: 10.1016/j.amjsurg.2018.10.017. [Epub ahead of print]

PMID:
30343874
9.

Perioperative antibiotics should be used for placement of implanted central venous ports: A propensity analysis evaluating risk.

Scaife CL, Mone MC, Bowen ME, Swords DS, Zhang C, Presson AP, Nelson EW.

Am J Surg. 2018 Dec;216(6):1135-1143. doi: 10.1016/j.amjsurg.2018.09.022. Epub 2018 Sep 21.

PMID:
30268417
10.

Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy.

Swords DS, Francis SR, Lloyd S, Garrido-Laguna I, Mulvihill SJ, Gruhl JD, Christensen MC, Stoddard GJ, Firpo MA, Scaife CL.

J Gastrointest Surg. 2018 Sep 5. doi: 10.1007/s11605-018-3953-0. [Epub ahead of print]

PMID:
30187332
11.

Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?

Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS.

Surgery. 2018 Dec;164(6):1178-1184. doi: 10.1016/j.surg.2018.07.014. Epub 2018 Aug 28.

PMID:
30170819
12.

Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy.

Nevala-Plagemann C, Francis S, Cavalieri C, Tao R, Whisenant J, Glasgow R, Scaife C, Lloyd S, Garrido-Laguna I.

ESMO Open. 2018 Jul 25;3(5):e000386. doi: 10.1136/esmoopen-2018-000386. eCollection 2018.

13.

Causes of Death and Conditional Survival Estimates of Medium- and Long-term Survivors of Pancreatic Adenocarcinoma.

Swords DS, Mulvihill SJ, Firpo MA, Scaife CL.

JAMA Oncol. 2018 Aug 1;4(8):1129-1130. doi: 10.1001/jamaoncol.2018.2442. No abstract available.

PMID:
30003235
14.

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins.

Torgeson A, Garrido-Laguna I, Tao R, Cannon GM, Scaife CL, Lloyd S.

ESMO Open. 2018 Jan 27;3(1):e000282. doi: 10.1136/esmoopen-2017-000282. eCollection 2018.

15.

Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.

Swords DS, Zhang C, Presson AP, Firpo MA, Mulvihill SJ, Scaife CL.

Surgery. 2018 Apr;163(4):753-760. doi: 10.1016/j.surg.2017.10.054. Epub 2017 Dec 13.

PMID:
29248179
16.

Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis.

Torgeson A, Lloyd S, Boothe D, Cannon G, Garrido-Laguna I, Whisenant J, Lewis M, Kim R, Scaife C, Tao R.

Ann Surg Oncol. 2017 Dec;24(13):4001-4008. doi: 10.1245/s10434-017-6131-9. Epub 2017 Oct 17.

PMID:
29043526
17.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
18.

Hospital-level Variation in Utilization of Surgery for Clinical Stage I-II Pancreatic Adenocarcinoma.

Swords DS, Mulvihill SJ, Skarda DE, Finlayson SRG, Stoddard GJ, Ott MJ, Firpo MA, Scaife CL.

Ann Surg. 2019 Jan;269(1):133-142. doi: 10.1097/SLA.0000000000002404.

PMID:
28700442
19.

A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency.

Rengifo-Cam W, Jasperson K, Garrido-Laguna I, Colman H, Scaife C, Samowitz W, Samadder NJ.

ACG Case Rep J. 2017 Mar 1;4:e34. doi: 10.14309/crj.2017.34. eCollection 2017.

20.

Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma.

Swords DS, Firpo MA, Johnson KM, Boucher KM, Scaife CL, Mulvihill SJ.

Surgery. 2017 Jul;162(1):104-111. doi: 10.1016/j.surg.2016.12.029. Epub 2017 Feb 21.

21.

Biomarkers in pancreatic adenocarcinoma: current perspectives.

Swords DS, Firpo MA, Scaife CL, Mulvihill SJ.

Onco Targets Ther. 2016 Dec 9;9:7459-7467. doi: 10.2147/OTT.S100510. eCollection 2016. Review.

22.

Enterovaginal or Vesicovaginal Fistula Control Using a Silicone Cup.

Russell KW, Robinson RE, Mone MC, Scaife CL.

Obstet Gynecol. 2016 Dec;128(6):1365-1368.

PMID:
27824744
23.

When body mass index fails to measure up: perinephric and periumbilical fat as predictors of operative risk.

Martin L, Seton G, Aldred B, Hopkins P, Chan J, Heilbrun ME, Mone M, Scaife C, Peche W.

Am J Surg. 2016 Dec;212(6):1039-1046. doi: 10.1016/j.amjsurg.2016.09.001. Epub 2016 Sep 28.

PMID:
27810136
24.

Reply: Should we operate for an intra-abdominal emergency in the setting of disseminated cancer?

Scaife CL, Mone MC.

Surgery. 2016 Jun;159(6):1693-1695. doi: 10.1016/j.surg.2016.02.026. Epub 2016 Apr 5. No abstract available.

PMID:
27059637
25.

Reply: Should we operate for an intraabdominal emergency in the setting of disseminated cancer?

Scaife CL, Hewitt K, Sheng X, Russell KW, Mone MC.

Surgery. 2016 Mar;159(3):981-3. doi: 10.1016/j.surg.2015.10.032. Epub 2015 Dec 29. No abstract available.

PMID:
26744244
26.

Surgeons help with recovery after earthquake in Nepal.

Katz M, Russell K, Cardinale D, White T, Reddish P, Scaife C.

Bull Am Coll Surg. 2015 Nov;100(11):24-8. No abstract available.

PMID:
26677533
27.

Routine endoscopic surveillance for local recurrence of rectal cancer is futile.

Martin LA, Gross ME, Mone MC, Whiting CK, Hansen HJ, Mecham EM, Peche W, Scaife CL.

Am J Surg. 2015 Dec;210(6):996-1001; discussion 1001-2. doi: 10.1016/j.amjsurg.2015.06.027. Epub 2015 Sep 11.

PMID:
26453291
28.

Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.

Hubbard D, Enda M, Bond T, Moghaddam SP, Conarton J, Scaife C, Volckmann E, Ghandehari H.

Mol Pharm. 2015 Nov 2;12(11):4099-107. doi: 10.1021/acs.molpharmaceut.5b00541. Epub 2015 Oct 12.

PMID:
26414679
29.

The Barcelona Technique for Ileostomy Reversal.

Russell KW, O'Holleran BP, Bowen ME, Mone MC, Scaife CL.

J Gastrointest Surg. 2015 Dec;19(12):2269-72. doi: 10.1007/s11605-015-2929-6. Epub 2015 Sep 4.

PMID:
26341822
30.

Initial Misdiagnosis of Proximal Pancreatic Adenocarcinoma Is Associated with Delay in Diagnosis and Advanced Stage at Presentation.

Swords DS, Mone MC, Zhang C, Presson AP, Mulvihill SJ, Scaife CL.

J Gastrointest Surg. 2015 Oct;19(10):1813-21. doi: 10.1007/s11605-015-2923-z. Epub 2015 Aug 19.

PMID:
26286368
31.

Should we operate for an intra-abdominal emergency in the setting of disseminated cancer?

Scaife CL, Hewitt K, Sheng X, Russell KW, Mone MC.

Surgery. 2015 Sep;158(3):636-45. doi: 10.1016/j.surg.2015.04.024. Epub 2015 Jun 16.

PMID:
26088921
32.

Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread.

Shen Y, Zificsak CA, Shea JE, Lao X, Bollt O, Li X, Lisko JG, Theroff JP, Scaife CL, Ator MA, Ruggeri BA, Dorsey BD, Kuwada SK.

J Med Chem. 2015 Feb 12;58(3):1140-58. doi: 10.1021/jm501437v. Epub 2015 Jan 26.

PMID:
25581261
33.

Wilderness Medical Society practice guidelines for the treatment of acute pain in remote environments: 2014 update.

Russell KW, Scaife CL, Weber DC, Windsor JS, Wheeler AR, Smith WR, Wedmore I, McIntosh SE, Lieberman JR; Wilderness Medical Society.

Wilderness Environ Med. 2014 Dec;25(4 Suppl):S96-104. doi: 10.1016/j.wem.2014.07.016.

PMID:
25498266
34.

Image-guided placement of long-term central venous catheters reduces complications and cost.

Bowen ME, Mone MC, Nelson EW, Scaife CL.

Am J Surg. 2014 Dec;208(6):937-41; discussion 941. doi: 10.1016/j.amjsurg.2014.08.005. Epub 2014 Sep 22.

PMID:
25440481
35.

Tumour eradication using synchronous thermal ablation and Hsp90 chemotherapy with protein engineered triblock biopolymer-geldanamycin conjugates.

Chen Y, Youn P, Pysher TJ, Scaife CL, Furgeson DY.

Int J Hyperthermia. 2014 Dec;30(8):550-64. doi: 10.3109/02656736.2014.974694. Epub 2014 Nov 18.

PMID:
25403416
36.

Hepatobiliary cancers, version 2.2014.

Benson AB 3rd, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H.

J Natl Compr Canc Netw. 2014 Aug;12(8):1152-82.

PMID:
25099447
37.

Wilderness Medical Society practice guidelines for the treatment of acute pain in remote environments.

Russell KW, Scaife CL, Weber DC, Windsor JS, Wheeler AR, Smith W, Wedmore I, McIntosh SE, Lieberman JR; Wilderness Medical Society.

Wilderness Environ Med. 2014 Mar;25(1):41-9. doi: 10.1016/j.wem.2013.10.001. Epub 2014 Jan 21.

PMID:
24462332
38.

Comparison of prospective risk estimates for postoperative complications: human vs computer model.

Glasgow RE, Hawn MT, Hosokawa PW, Henderson WG, Min SJ, Richman JS, Tomeh MG, Campbell D, Neumayer LA; DS3 Study Group.

J Am Coll Surg. 2014 Feb;218(2):237-45.e1-4. doi: 10.1016/j.jamcollsurg.2013.10.027. Epub 2013 Nov 13.

39.

Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.

Kendrick ZW, Firpo MA, Repko RC, Scaife CL, Adler DG, Boucher KM, Mulvihill SJ.

HPB (Oxford). 2014 Jul;16(7):670-6. doi: 10.1111/hpb.12199. Epub 2013 Dec 6.

40.

Does travel distance influence length of stay in elective pancreatic surgery?

Jackson KL, Glasgow RE, Mone MC, Sheng X, Mulvihill SJ, Scaife CL.

HPB (Oxford). 2014 Jun;16(6):543-9. doi: 10.1111/hpb.12180. Epub 2013 Nov 7.

41.

A survey of American College of Surgery fellows evaluating their use of antibiotic prophylaxis in the placement of subcutaneously implanted central venous access ports.

Nelson ET, Gross ME, Mone MC, Hansen HJ, Nelson EW, Scaife CL.

Am J Surg. 2013 Dec;206(6):1034-9; discussion 1039-40. doi: 10.1016/j.amjsurg.2013.07.019. Epub 2013 Oct 16.

PMID:
24139669
42.

Umbilical paracentesis for acute hernia reduction in cirrhotic patients.

Russell KW, Mone MC, Scaife CL.

BMJ Case Rep. 2013 Oct 16;2013. pii: bcr2013201304. doi: 10.1136/bcr-2013-201304.

43.

Association between postoperative complications and clinical cancer outcomes.

Scaife CL, Hartz A, Pappas L, Pelletier P, He T, Glasgow RE, Mulvihill SJ.

Ann Surg Oncol. 2013 Dec;20(13):4063-6. doi: 10.1245/s10434-013-3267-0. Epub 2013 Sep 20.

PMID:
24052315
44.

Comparison of intraoperative versus delayed enteral feeding tube placement in patients undergoing a Whipple procedure.

Scaife CL, Hewitt KC, Mone MC, Hansen HJ, Nelson ET, Mulvihill SJ.

HPB (Oxford). 2014 Jan;16(1):62-9. doi: 10.1111/hpb.12072. Epub 2013 Mar 8.

45.

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.

Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ.

Pancreas. 2013 Mar;42(2):193-7. doi: 10.1097/MPA.0b013e31825e354d.

46.

Does travel distance influence length of stay in elective colorectal surgery?

Jackson KL, Glasgow RE, Hill BR, Mone MC, Sklow B, Scaife CL, Sheng X, Peche WJ.

Dis Colon Rectum. 2013 Mar;56(3):367-73. doi: 10.1097/DCR.0b013e31827e939e.

PMID:
23392153
47.

Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model.

Rapoport N, Payne A, Dillon C, Shea J, Scaife C, Gupta R.

J Ther Ultrasound. 2013 Jul 1;1:11. doi: 10.1186/2050-5736-1-11. eCollection 2013.

48.

Identification of factors predictive of malignancy in patients with atypical biliary brushing results obtained via ERCP.

Witt BL, Kristen Hilden RN, Scaife C, Chadwick B, Layfield L, Cory Johnston W, Safaee M, Siddiqui A, Adler DG.

Diagn Cytopathol. 2013 Aug;41(8):682-8. doi: 10.1002/dc.22924. Epub 2012 Sep 25.

PMID:
23008113
49.

Exploiting antitumor immunity to overcome relapse and improve remission duration.

Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Randall RL, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS.

Cancer Immunol Immunother. 2012 Jul;61(7):1113-24. doi: 10.1007/s00262-011-1185-1. Epub 2011 Dec 24.

50.

Roux-en-Y drainage of a pancreatic fistula for disconnected pancreatic duct syndrome after acute necrotizing pancreatitis.

Pearson EG, Scaife CL, Mulvihill SJ, Glasgow RE.

HPB (Oxford). 2012 Jan;14(1):26-31. doi: 10.1111/j.1477-2574.2011.00397.x. Epub 2011 Oct 31.

Supplemental Content

Loading ...
Support Center